Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman Sells 810 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 810 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the sale, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Intuitive Surgical Stock Down 1.1 %

ISRG opened at $566.98 on Tuesday. The firm has a 50-day simple moving average of $570.66 and a two-hundred day simple moving average of $530.08. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market capitalization of $201.95 billion, a PE ratio of 88.45, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Finally, UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Institutional Trading of Intuitive Surgical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.